Inogen Inc Asset Resilience Ratio
Inogen Inc asset resilience ratio. Inogen Inc (INGN) has an Asset Resilience Ratio of 5.97% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Inogen Inc fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Inogen Inc (2014–2025)
Asset resilience ratio of Inogen Inc from 2014 to 2025. This chart shows how Inogen Inc's Asset Resilience Ratio has changed over time. Read INGN total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Inogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Inogen Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $17.06 Million | 5.97% |
| Total Liquid Assets | $17.06 Million | 5.97% |
Asset Resilience Insights
- Limited Liquidity: Inogen Inc maintains only 5.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Inogen Inc Industry Peers by Asset Resilience Ratio
Compare Inogen Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Inogen Inc Asset Resilience Ratio by Year (2014–2025)
Inogen Inc asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for Inogen Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.31% | $15.85 Million | $298.62 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $296.19 Million | -- |
| 2023-12-31 | 0.91% | $2.98 Million | $326.19 Million | -- |
| 2022-12-31 | 0.00% | $0.00 | $405.04 Million | -- |
| 2021-12-31 | 2.04% | $9.99 Million | $489.51 Million | -2.13pp |
| 2020-12-31 | 4.17% | $19.26 Million | $461.85 Million | +1.70pp |
| 2019-12-31 | 2.47% | $11.06 Million | $447.34 Million | -9.16pp |
| 2018-12-31 | 11.63% | $43.72 Million | $375.90 Million | +0.36pp |
| 2017-12-31 | 11.27% | $30.99 Million | $275.07 Million | +1.44pp |
| 2016-12-31 | 9.83% | $21.03 Million | $214.05 Million | -0.58pp |
| 2015-12-31 | 10.41% | $16.79 Million | $161.31 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $140.09 Million | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more